Navigation Links
Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune

ngoing phase 1 study, MT103/MEDI-538 has shown potent elimination of tumor target cells in peripheral blood, bone marrow, lymph nodes and spleen of therapy- refractory non-Hodgkins lymphoma patients.

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases. Two product candidates are currently in clinical trials. MT103/MEDI-538, which is the first product candidate based on Micromet's novel BiTE(R) product development platform, is being evaluated in a phase 1 clinical trial for the treatment of patients with non-Hodgkins lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, the most powerful 'killer cells' of the human immune system. Adecatumumab (MT201), a recombinant human monoclonal antibody which targets EpCAM expressing tumors, has completed two phase 2a clinical trials, one in patients with breast cancer and the other in patients with prostate cancer. In addition, a phase 1b trial evaluating the safety and tolerability of MT201 in combination with docetaxel is currently ongoing in patients with metastatic breast cancer. Micromet has established collaborations with MedImmune, Inc. for MT103/MEDI-538 and Merck Serono for adecatumumab (MT201).

Forward-Looking Statements of Micromet, Inc.

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding the intended utilization of product candidates, the conduct and results of future clinical trials, plans regarding regulatory fi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
4. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
5. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
8. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
9. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
10. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
11. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results

Post Your Comments:
(Date:11/25/2009)... , WEST PALM BEACH, Fla., Nov. 25 /PRNewsw...ing impaired Americans, especially the 27 million ... may not be all that happy, says audiologist Cindy...HearUSA (Amex: EAR ), one of America,s largest he...ies have linked hearing loss to stress, frustratio...
(Date:11/25/2009)... , BASKING RIDGE, N.J., Nov. 25 /PRNewswire...leading the development of antithrombotic aptamers...Mazzo, PhD, CEO and President, will be presenting ...rence at the New York Palace Hotel in New York Cit...pm (EST) on Tuesday, December 1 and will include a...
(Date:11/25/2009)... , NEW YORK, Nov. 25 R...ch report is available in its catalogue: ,, M... ,, http://www.reportlinker.com/p0164330/Mam...tml ,, Rising incidence of breast cancer in in...incipal factor influencing growth in the mammograp...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8New Treatment May Beat Melanoma 58326 1New Treatment May Beat Melanoma 58326 2New Treatment May Beat Melanoma 58326 3Surgery Best for Carpal Tunnel Syndrome 58324 1Surgery Best for Carpal Tunnel Syndrome 58324 2Surgery Best for Carpal Tunnel Syndrome 58324 3Antidepressants Linked to Heart Defects in Newborns 58322 1Antidepressants Linked to Heart Defects in Newborns 58322 2Antidepressants Linked to Heart Defects in Newborns 58322 3
(Date:11/29/2009)...urine production, experts say , , SUNDA...during the night to urinate shouldn,t automaticall...hing-related sleep disorder, could be the cause. ,... or nocturia, is comparable to loud snoring as a m...hich soft tissue in the throat blocks the flow of ...
(Date:11/28/2009)... Get ready for advanced visualization to become ...iemens introduces syngo. via(1) at the 95th...iological Society of North America (RSNA) from Nov...825, East Building/Lakeside Center, Hall D) in Chi...ng software for multimodality reading of clinical ...
(Date:11/27/2009)...e-FirstCall/ -- GSI Group Inc. (Pink Sheets: GSIGQ...gy products and semiconductor systems, today annou...holders has been scheduled for Friday, April 30, 2... announced in due course. As previously announced...tephen Bershad, a holder of greater than ten perce...
(Date:11/27/2009)...irstCall/ -- The Gymboree Corporation (Nasdaq: GY...resent at the NASDAQ OMX 23rd Investor Program, wh...England, on Wednesday, December 2, 2009, at 11:45 ...he Gymboree Corporation,s presentation over the In...n "Our Company" at the bottom of the page, go to "...
(Date:11/27/2009)... announced that it has become a national sponsor o...profit organizations dedicated to arthritis resear... Delray Beach, FL (Vocus) November 27, 200...any specializing in the marketing and retail distr...nced today that is has become a national sponsor o...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
...obert S. Kunkel, M.D., CLEVELAND, Oct. 26 It,s n...t lying down! Cleveland Clinic Press,( http://www....veland Clinic,( http://www.clevelandclinic.org/ ),...com.com/cgi-bin/prnh/20070906/CLTH130LOGO ) This...
...r how much we eat, but research suggests that cult...ppropriate portion sizes. Just in time for the,hol...men,s Health Watch,looks into how misperceptions a...serving is a specific quantity of,food designated ...
...to a,$50,000 donation made earlier this week from ...rican Red Cross to aid in the disaster relief in,S...eral additional actions,they are taking to assist ...r the next 30 days to all,Blue Cross members throu...
...nd early detection, , , FRIDAY, Oct. 26 (H...women think that if there,s no family history of c... new survey found. , In fact, most people who deve...The survey underscores the need for better educati...
...tunities, LAS VEGAS, Oct. 26 As part of its stra...d pharmaceutical contacts,Skinvisible, Inc. (OTC B...,the developers of Invisicare(R), a patented polym...ionally renowned,plastic and reconstructive surgeo...
..., WASHINGTON, Oct. 26 The Alliance of,Community ...t of its member,plans have been recognized by the ...tee for Quality Assurance (NCQA) as being among th...ovide coverage and,health care services for nearly...
Other Medicine News:Health News:Cleveland Clinic Press Releases Consumer Health Book About Treating Headache Pain 2Health News:Tips for Keeping Food Portions Under Control, from Harvard Women's Health Watch 2Health News:Blue Cross of California Reaches Out to Members Impacted by Southern California Fires 2Health News:Survey Finds Many Women Misinformed About Cancer 2Health News:Survey Finds Many Women Misinformed About Cancer 3Health News:Skinvisible Appoints Dr. George Korkos to Its Advisory Board 2Health News:Skinvisible Appoints Dr. George Korkos to Its Advisory Board 3Health News:Community Health Plans Among Best in Nation 2Health News:Community Health Plans Among Best in Nation 3Health News:Community Health Plans Among Best in Nation 4Health News:Community Health Plans Among Best in Nation 5
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: